Criterion Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$1.7K Hold
7
﹤0.01% 329
2024
Q3
$1.7K Hold
7
﹤0.01% 329
2024
Q2
$1.7K Hold
7
﹤0.01% 329
2024
Q1
$1.05K Hold
7
﹤0.01% 333
2023
Q4
$1.34K Buy
+7
New +$1.34K ﹤0.01% 334